Xeltis announced today that its Board of Directors has nominated Michel Darnaud to stand for election at the company’s Annual Meeting of Shareholders currently scheduled for June 1, 2015. Michel Darnaud is a medical device veteran with more than 30 years in leadership roles at major cardiovascular device companies. “With its game-changing technology, Xeltis is setting a new industry benchmark in the cardiovascular field, a worldwide growth market. I look forward to participating to the development of such a disruptive new player“, says Michel Darnaud. Laurent Grandidier, CEO of Xeltis, states: “We are on a mission to transform standards of care in cardiovascular treatments by replacing permanent prosthesis by a new generation of bioabsorbable devices. We believe our technology will have a profound, positive impact on clinical practice, benefiting both patients and physicians. We are delighted that Michel has agreed to join Xeltis to help the company deliver on this promise.”
